Alexandria Real Estate EquitiesNYSE: ARE
Real Estate · Office REITs
$51.09
+3.81%
Vol: 1.2M
Research Digest
Friday, June 19, 2026
Alexandria Real Estate declares $0.72 Q2 2026 quarterly dividend and ranks as second most active NYC life science investor.
Alexandria Real Estate Equities declared a quarterly cash dividend of $0.72 per common share for Q2 2026 on June 1, 2026, payable July 15 to stockholders of record June 30, consistent with its focus on balance sheet strength and liquidity preservation. On June 9, Alexandria highlighted its position as the second most active early-stage life science investor in New York City, reinforcing its leadership in building and operating collaborative Megacampus ecosystems. On June 15, the company was recognized by The Wall Street Journal as 16th among all S&P 500 companies and the highest-ranked equity REIT for talent readiness in its 'Best Companies for the Future' list. These announcements are largely routine for a life science REIT and carry low immediate stock-moving impact, but reinforce the quality of ARE's platform and tenant base amid a challenging environment for office and lab space REITs.
Previous Market Intelligence
13 daysJun 18No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 17No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 16No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21Alexandria Real Estate shares rose 3.58% on May 20 to $47.50 amid heavy insider buying from Executive Chairman Joel Marcus ($730K+ in early May), though Goldman, Baird and Cantor cut price targets significantly.Mixed▶
Alexandria Real Estate Equities saw notable insider buying in May with Executive Chairman Joel S. Marcus acquiring 10,000 shares on May 4 for $410,200 and another 7,500 shares on May 5 for $320,416, at prices between $40.64-$42.72, signaling confidence as shares trade near 52-week lows. The May 13 annual meeting saw shareholders re-elect eight directors and approve executive pay and Ernst & Young as auditors. However, analyst sentiment has soured significantly: Goldman Sachs cut its price target to $52 from $60 on May 14, Baird downgraded to Neutral from Outperform cutting PT to $46 from $67, and Cantor Fitzgerald cut to $43 from $60. The company faces challenges from a 45% dividend cut, weak life-science tenant demand, oversupply of properties, and development funding commitments. Q1 2026 EPS of $2.10 beat the $0.15 forecast significantly, but revenue of $671M missed expectations. Stock closed at $47.50 on May 20 (up 3.58%).
May 20Alexandria Real Estate executive chairman buys $410K in stock; Baird downgrades to Neutral with PT cut to $46.Negative▶
Executive Chairman Joel S. Marcus acquired 10,000 shares for $410,200 on May 4, with insider purchases totaling $1.81M over the past 90 days, signaling confidence amid challenges. However, Baird downgraded Alexandria to Neutral from Outperform and slashed its price target to $46 from $67, citing a slower-than-anticipated recovery. Cantor Fitzgerald cut its PT to $43 from $60 (Neutral). Q1 2026 showed an EPS of $2.10 (vs. $0.15 forecast, 1300% surprise) but revenue missed at $671M vs. $684M expected. The company previously cut its dividend by 45%. The annual shareholder meeting was held on May 13 with directors elected and Ernst & Young ratified as auditor.
May 19Alexandria Executive Chairman Joel Marcus buys $730K of stock in early May; Baird downgrades to Neutral, cuts PT to $46 from $67.Mixed▶
Alexandria Real Estate Equities Executive Chairman Joel S. Marcus purchased 10,000 shares on May 4 ($410,200) and 7,500 shares on May 5 ($320,416), totaling ~$730,000 at prices of $40.64-$41.58, near the stock's 52-week low of $39.41 after a ~40% one-year decline. Total insider buying reached $1.81 million over the prior 90 days. The May 13 annual meeting saw stockholders elect eight directors, approve advisory executive comp, and ratify Ernst & Young as auditor. Q1 2026 EPS of $2.10 beat the $0.15 forecast by 1300%, though revenue of $671.02M missed expectations of $684.24M; FY26 EPS guidance stands at $6.30-$6.50. Baird downgraded the stock to Neutral from Outperform, cutting its price target to $46 from $67 citing a slower recovery timeline, while Cantor Fitzgerald lowered its target to $43 from $60 (Neutral).
May 18Alexandria Real Estate Executive Chairman Joel Marcus bought 7,500 additional shares ($320,416) on May 5 after a 10,000-share purchase the previous day, with Baird downgrading to Neutral and cutting PT to $46.Mixed▶
Executive Chairman Joel S. Marcus continued his insider buying campaign with a 7,500-share purchase for $320,416 on May 5, 2026, one day after a 10,000-share purchase for $410,200 on May 4, signaling confidence in the company outlook. The buying came amid significant analyst pressure: Baird downgraded Alexandria to Neutral from Outperform and cut its price target from $67 to $46, while Cantor Fitzgerald also cut its target to $43 from $60 with a Neutral rating. Alexandria reported Q1 2026 EPS of $2.10 (vs $0.15 expected, a 1,300% surprise) but revenue of $671.02M missed the $684.24M estimate. Alexandria May 13 annual meeting addressed director elections and EY ratification. The company faces challenges with a 45% dividend cut due to weak tenant demand and broader market pressures. Insider buying offsets analyst pessimism.
May 15Alexandria Real Estate hit by Baird downgrade and big PT cuts as analyst consensus targets $51.25Negative▶
Alexandria Real Estate Equities faces mounting pressure with Q1 2026 revenue down 11.5% YoY to $671M and a 45% dividend cut, though EPS of $1.73 was in line. Baird downgraded ARE to Neutral from Outperform and cut its PT to $46 from $67 citing a slower-than-expected recovery; RBC Capital trimmed PT to $50 from $60. Consensus across 15 analysts is Hold (2 Buys / 11 Holds / 2 Sells) with a 12-month target of $51.25 (~10% upside). Executive Chairman Joel S. Marcus showed confidence by buying 10,000 shares for $410,200 on May 4, part of $1.81M total insider purchases over 90 days. Lower occupancy and higher interest expense remain headwinds.
May 14Alexandria Real Estate annual meeting May 13 follows Baird downgrade to Neutral and $46 PT cut; executive chairman buys $730K of sharesMixed▶
Alexandria Real Estate held its annual shareholder meeting on May 13, 2026 to elect eight directors, approve executive compensation and ratify Ernst & Young as auditor. Executive Chairman Joel S. Marcus showed strong insider conviction, purchasing 10,000 shares for $410,200 on May 4 and an additional 7,500 shares for $320,416 on May 5; insider purchases total $1.81M over the trailing 90 days. Q1 2026 EPS was $2.10 (far above $0.15 forecast) but revenue of $671.02M missed $684.24M consensus. FY26 EPS guidance is $6.30-$6.50. Baird downgraded ARE to Neutral from Outperform and slashed its price target to $46 from $67, citing a slower-than-anticipated recovery and more gradual operating improvement. Risk: continued weakness in life sciences leasing demand and supply overhang in lab space.
May 13Baird downgraded Alexandria Real Estate to Neutral from Outperform with PT cut to $46 from $67 on slower recovery, while Executive Chairman Joel Marcus bought $410K of stock on May 4 ahead of the May 13 annual meeting.Negative▶
Baird downgraded ARE to Neutral from Outperform, slashing its price target to $46 from $67 and citing a slower-than-anticipated recovery timeline in life science real estate leasing. Q1 2026 EPS of $1.73 met consensus but revenue of $671.02M missed analyst estimates of $684.78M. Executive Chairman and founder Joel S. Marcus made open-market purchases totaling 10,000 shares ($410,200) on May 4, followed by 7,500 more shares on May 5 — a notable signal of insider confidence. The annual stockholder meeting is on May 13, with eight directors up for election and EY to be ratified as auditor. Marcus will receive the Richard J. Bolte Sr. Award from the Science History Institute. Risks include continued leasing softness in life science properties and biotech tenant demand uncertainty.
May 12Alexandria Real Estate executive chairman Joel Marcus disclosed insider purchases of $320,415 on May 5 ahead of the May 13 annual meeting; Baird downgraded the stock to Neutral.Mixed▶
Executive Chairman and founder Joel S. Marcus bought 7,500 shares of Alexandria Real Estate worth $320,415 on May 5, 2026 at prices of $41.89-$43.70, an insider buy that often signals confidence at depressed valuations. Marcus also received the Richard J. Bolte Sr. Award on May 6 from the Science History Institute. The annual meeting is scheduled for May 13, 2026 to elect eight directors, vote on executive comp, and ratify EY as auditor. Bear case: Baird downgraded ARE to Neutral from Outperform and cut its price target to $46 from $67, citing a slower-than-anticipated life-science leasing recovery, and shares trade near multi-year lows around the low-$40s as the lab-space vacancy overhang persists.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| BXPBXP | $64.81 | +2.78% | +8.0% | 30.4x | 1.06 | $11.5B |
| AREALEXANDRIA | $51.09 | +3.81% | +6.7% | -58.0x | 1.20 | $8.9B |
| WELLWELLTOWER | $206.76 | +0.10% | -5.5% | 61.5x | 0.78 | $145.9B |
| PLDPROLOGIS | $140.80 | -0.10% | -2.9% | 41.9x | 1.33 | $131.7B |
| EQIXEQUINIX | $1,092.30 | +0.35% | +2.5% | 56.8x | 0.97 | $107.7B |
| AMTAMERICAN | $175.68 | -2.99% | -4.3% | 25.5x | 0.89 | $82.0B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price below 200d MA — bearish structure.